Fig. 2
From: Scleritis following intravitreal brolucizumab injection: a case series
Clinical findings in Case 2. A Significant upper scleritis was observed in the right eye after the fifth intravitreal brolucizumab injection. B Scleritis improved after treatment with topical eye drops. C Upper scleritis worsened after the seventh intravitreal brolucizumab injection. D There was vitreous opacification but no retinal vasculitis or retinal vascular occlusion. The optical coherence tomography image was unclear because of vitreous opacification. E Scleritis and vitreous opacity improved